Atrophic Scar Treatment Market

Global Market Study on Atrophic Scar Treatment: Close Fight Between APAC and Europe Markets in Terms of both Revenue Share and Growth Rate

Atrophic Scar Treatment Market Segmented By Gels, Creams, Oils Topical Product and CO2 Lasers, Pulsed Dye Laser, Surface treatment, Injectable in Hospitals, Clinics, Pharmacies and drug stores, E-Commerce

Industry: Healthcare

Published Date: March-2018

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 227

Report ID: PMRREP22468

Report Price

$ 4900*

Buy Now

Introduction

The US$ 4.65 Bn global atrophic scar treatment market is presumed to exhibit 1.3x growth by the end of 2025. Over the forecast period 2017-2025, the global market for atrophic scar treatment will reportedly grow at a CAGR of 4.6%. The overall outlook remains moderate yet positive.

Multiple affirmative factors to drive atrophic scar treatment market growth

While soaring demand for atrophic scar treatment and evolving regulatory landscape in developed as well as developing economies are identified to predominantly fuel the market growth within the assessment period, the report also throws light on a range of other prominent drivers responsible for steady growth of the global atrophic scar treatment market.

  • Rising instances of skin disorders
  • Growing need for advanced treatment alternatives and product innovations
  • Growing demand for age-defying treatment therapies worldwide
  • Surging awareness and preference for personal care
  • Improving economy of emerging countries
  • Increasing healthcare expenditure by consumers as well as governments
  • Favorable reimbursement scenario in certain developed countries
  • International exchange of treatment ideas and scope widens growth opportunities
  • Increasing consumer demand for short treatment period offering quick results

Topical scar treatment to remain most preferred type during the period of study

Based on product type, the global market for atrophic scar treatment is segmented into topical scar products, laser products, surface treatment, and injectable products. Among these four, topical scar product segment will continue to dominate with over 50% value share despite a slight decline in the market share by 2025 end. Laser segment is expected to witness a declined market share by value but laser therapy is emerging as a popular treatment among affluent consumers.

Surface treatment is likely to capture over 20% share of the total market value by 2025 end, followed by injectables. An important observation by Persistence Market Research indicates that topical treatments are gradually losing popularity among wealthy consumer pockets, whereas lasers and injectables are gaining evidently higher traction. However, expensive pricing of the latter two are still a major constraint that will persist throughout the forecast period.

atrophic scar treatment market

Latin America to emerge most lucrative regional market

Among the various regional markets, North America is foreseen to remain dominant, possibly reaching revenue beyond US$ 2.6 Bn by 2025 end. APAC is identified to be the second largest regional market for atrophic scar treatment, closely trailed by Europe. China, India, and Japan will be the key regions within the Asian Pacific rim.

While MEA seems to be a stably growing market, Latin America is expected to witness the fastest growth over the forecast period. According to Persistence Market Research, the market in Latin America will be most lucrative for leading players, led by Brazil due to growing popularity of cosmetic interventions.

Market Taxonomy

The global market for atrophic scar treatment has been classified on the basis of product type and end-user. The report analyses each segment and sub-segment to provide historical, current, and estimated scenario in the global atrophic scar treatment market during the assessment period.

Attribute Details

Product Type

  • Topical
    • Gels
    • Creams
    • Oils
  • Laser
    • CO2 Lasers
    • Pulsed Dye Laser
  • Surface treatment
  • Injectable

Distribution Channel

  • Hospitals
  • Clinics
  • Pharmacies and drug stores
  • E-Commerce
Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Questions Answered

  • How the market has performed over the past few years?
  • What have been the challenges for market participants and how did they overcome them?
  • How has the technology landscape evolved over the past years?
  • How the competitors have performed and what have been their growth strategies?
  • What is the market potential expected to look like in near future across the globe?
  • How to sustain and grow market share?
  • What should be the future course of action?
  • Where do I currently stand?
  • Which are the segments, factors, regions offering promising growth potential?
  • What are the trends in the market and am I ready for them?

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • Merz Inc.
  • Enaltus LLC
  • Oculus Innovative Sciences Inc.
  • CCA Industries Inc.
  • Cynosure Inc.
  • LUMENIS
  • Syneron Medical Ltd.
  • NutraMarks Inc.
  • Mölnlycke Health Care
  • Pacific World Corporation
  • Valeant Pharmaceuticals International Inc
  • Shanghai Fosun Pharmaceuticals Ltd(ACAlma Lasers)
  • Beijing Toplaser Technology Co. Ltd
  • Sonoma Pharmaceuticals Inc.
  • Others

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate